Aurelija Jucaite

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

PET imaging of mitochondrial complex-I in the adenine-induced tubulointerstitial nephropathy mouse model using [18F]BCPP-BF.

PET imaging of mitochondrial complex-I in the adenine-induced tubulointerstitial nephropathy mouse model using [18F]BCPP-BF.

Journal: EJNMMI radiopharmacy and chemistry
Published: July 07, 2025

Re-PERFUSE: Phase 1b study of AZD3427, a novel relaxin receptor agonist, on renal perfusion in HFrEF patients.

Re-PERFUSE: Phase 1b study of AZD3427, a novel relaxin receptor agonist, on renal perfusion in HFrEF patients.

Journal: ESC heart failure
Published: May 15, 2025

Brain exposure of the mesenchymal-epithelial transition inhibitor savolitinib in nonhuman primates: A positron emission tomography study.

Brain exposure of the mesenchymal-epithelial transition inhibitor savolitinib in nonhuman primates: A positron emission tomography study.

Journal: The Journal of pharmacology and experimental therapeutics
Published: October 07, 2024

Putative mapping of α-subunits in the human brain: A PET study of GABA A receptor binding.

Putative mapping of α-subunits in the human brain: A PET study of GABA A receptor binding.

Journal: Imaging neuroscience (Cambridge, Mass.)
Published: June 04, 2024

Subtype-selective positron emission tomography imaging of poly ADP-ribose polymerase-1 binding in non-human primates, healthy volunteers, and patients with glioblastoma using [11C]AZ14193391.

Subtype-selective positron emission tomography imaging of poly ADP-ribose polymerase-1 binding in non-human primates, healthy volunteers, and patients with glioblastoma using [11C]AZ14193391.

Journal: Neuro-oncology
Published: May 08, 2024

Brain exposure of osimertinib in patients with epidermal growth factor receptor mutation non-small cell lung cancer and brain metastases: A positron emission tomography and magnetic resonance imaging study.

Brain exposure of osimertinib in patients with epidermal growth factor receptor mutation non-small cell lung cancer and brain metastases: A positron emission tomography and magnetic resonance imaging study.

Journal: Clinical and translational science
Published: November 16, 2022

Proof of lung muscarinic receptor occupancy by tiotropium: Translational Positron Emission Tomography studies in non-human primates and humans.

Proof of lung muscarinic receptor occupancy by tiotropium: Translational Positron Emission Tomography studies in non-human primates and humans.

Journal: Frontiers in nuclear medicine
Published: October 25, 2022

Glia Imaging Shows Clinical Utility in Differentiating Parkinson's Disease from Multiple System Atrophy.

Glia Imaging Shows Clinical Utility in Differentiating Parkinson's Disease from Multiple System Atrophy.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: April 23, 2022

Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11 C]PBR28 and Machine Learning Analysis.

Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11 C]PBR28 and Machine Learning Analysis.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: May 04, 2021

Brain exposure of the ATM inhibitor AZD1390 in humans-a positron emission tomography study.

Brain exposure of the ATM inhibitor AZD1390 in humans-a positron emission tomography study.

Journal: Neuro-oncology
Published: October 30, 2020

First Radiolabeling of a Ganglioside with a Positron Emitting Radionuclide: In Vivo PET Demonstrates Low Exposure of Radiofluorinated GM1 in Non-human Primate Brain.

First Radiolabeling of a Ganglioside with a Positron Emitting Radionuclide: In Vivo PET Demonstrates Low Exposure of Radiofluorinated GM1 in Non-human Primate Brain.

Journal: ACS chemical neuroscience
Published: April 24, 2020

Nondisplaceable Binding Is a Potential Confounding Factor in 11C-PBR28 Translocator Protein PET Studies.

Nondisplaceable Binding Is a Potential Confounding Factor in 11C-PBR28 Translocator Protein PET Studies.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 17, 2020
Showing 1-12 of 28

Last Updated: 09/26/2026